Label: STAY AWAKE- caffeine 200 mg tablets tablet
- NDC Code(s): 68210-4151-2
- Packager: Spirit Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 11, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Purpose
- INDICATIONS & USAGE
- WARNINGS
- WHEN USING
- STOP USE
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
- OVERDOSAGE
- DOSAGE & ADMINISTRATION
- SPL UNCLASSIFIED SECTION
-
INACTIVE INGREDIENT
carnauba wax*,croscarmellose sodium, colloidal silicon
dioxide*, dextrates*, D&C yellow #10 aluminum lake,
dicalcium phosphate*, FD&C red#40 lake*, FD&C yellow
#6 aluminum lake*, hypromellose, lactose*, magnesium
stearate, microcrystalline cellulose, polyethylene glycol,
silicon dioxide*, titanium dioxide
*contains one or more of these ingredients - QUESTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
STAY AWAKE
caffeine 200 mg tablets tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68210-4151 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE 200 mg Inactive Ingredients Ingredient Name Strength CARNAUBA WAX (UNII: R12CBM0EIZ) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6) DEXTRATES (UNII: G263MI44RU) ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J) FD&C RED NO. 40 (UNII: WZB9127XOA) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color yellow Score no score Shape ROUND Size 1mm Flavor Imprint Code ET38;AZ076;TCL343 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68210-4151-2 1 in 1 CARTON 04/29/2021 1 20 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M011 04/29/2021 Labeler - Spirit Pharmaceuticals LLC (179621011)